rs9297976

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NR_033343.2(PSCA):​n.272+249T>C variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.411 in 152,068 control chromosomes in the GnomAD database, including 12,944 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 12944 hom., cov: 32)

Consequence

PSCA
NR_033343.2 intron, non_coding_transcript

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.28
Variant links:
Genes affected
PSCA (HGNC:9500): (prostate stem cell antigen) This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene includes a polymorphism that results in an upstream start codon in some individuals; this polymorphism is thought to be associated with a risk for certain gastric and bladder cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
JRK (HGNC:6199): (Jrk helix-turn-helix protein) This gene encodes a conserved protein that is similar to DNA-binding proteins, such as major centromere autoantigen B (CENPB). Inactivation of the related gene in mice resulted in epileptic seizures. Childhood Absence Epilepsy (CAE) has been mapped to the same chromosomal location (8q24.3) as this gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.423 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PSCANR_033343.2 linkuse as main transcriptn.272+249T>C intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PSCAENST00000505305.1 linkuse as main transcriptn.261+249T>C intron_variant, non_coding_transcript_variant 3
PSCAENST00000510969.1 linkuse as main transcriptn.248+249T>C intron_variant, non_coding_transcript_variant 2
JRKENST00000591357.5 linkuse as main transcriptn.265-685A>G intron_variant, non_coding_transcript_variant 4

Frequencies

GnomAD3 genomes
AF:
0.411
AC:
62520
AN:
151952
Hom.:
12940
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.415
Gnomad AMI
AF:
0.478
Gnomad AMR
AF:
0.387
Gnomad ASJ
AF:
0.390
Gnomad EAS
AF:
0.322
Gnomad SAS
AF:
0.350
Gnomad FIN
AF:
0.405
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.427
Gnomad OTH
AF:
0.427
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.411
AC:
62543
AN:
152068
Hom.:
12944
Cov.:
32
AF XY:
0.408
AC XY:
30293
AN XY:
74334
show subpopulations
Gnomad4 AFR
AF:
0.414
Gnomad4 AMR
AF:
0.387
Gnomad4 ASJ
AF:
0.390
Gnomad4 EAS
AF:
0.322
Gnomad4 SAS
AF:
0.350
Gnomad4 FIN
AF:
0.405
Gnomad4 NFE
AF:
0.427
Gnomad4 OTH
AF:
0.421
Alfa
AF:
0.343
Hom.:
2191
Bravo
AF:
0.412
Asia WGS
AF:
0.303
AC:
1063
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.49
DANN
Benign
0.61

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs9297976; hg19: chr8-143752235; API